Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Bax

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Arthritis and Rheumatism|July 1, 1994
Bone mineral density of the hand in rheumatoid arthritisN F Peel, A J Spittlehouse, D E Bax, et al.
Annals of the Rheumatic Diseases|August 29, 2009
A gain of function polymorphism in the interleukin 6 receptor influences RA susceptibilityI Marinou, K Walters, J Winfield, et al.
British Journal of Rheumatology|December 1, 1991
Arthritis artefacta: factitious disease in rheumatologyR S Amos, D E Bax, J T Bourne, et al.
Annals of the Rheumatic Diseases|October 1, 1995
Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritisN F Peel, D J Moore, N A Barrington, et al.
British Medical Journal (Clinical Research Ed.)|August 16, 1986
Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 yearsR S Amos, T Pullar, D E Bax, et al.
Annals of the Rheumatic Diseases|August 30, 2008
Evidence of epistasis between interleukin 1 and selenoprotein-S with susceptibility to rheumatoid arthritisI Marinou, K Walters, M C Dickson, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 6, 2000
Prevention of bone loss with risedronate in glucocorticoid-treated rheumatoid arthritis patientsR Eastell, J P Devogelaer, N F Peel, et al.
Clinical and Experimental Rheumatology|January 2, 2003
TNF +489 polymorphism does not contribute to susceptibility to rheumatoid arthritisA S Low, M A Gonzalez-Gay, M Akil, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Arthritis and Rheumatism|July 1, 1994
Bone mineral density of the hand in rheumatoid arthritisN F Peel, A J Spittlehouse, D E Bax, et al.
Annals of the Rheumatic Diseases|August 29, 2009
A gain of function polymorphism in the interleukin 6 receptor influences RA susceptibilityI Marinou, K Walters, J Winfield, et al.
British Journal of Rheumatology|December 1, 1991
Arthritis artefacta: factitious disease in rheumatologyR S Amos, D E Bax, J T Bourne, et al.
Annals of the Rheumatic Diseases|October 1, 1995
Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritisN F Peel, D J Moore, N A Barrington, et al.
British Medical Journal (Clinical Research Ed.)|August 16, 1986
Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 yearsR S Amos, T Pullar, D E Bax, et al.
Annals of the Rheumatic Diseases|August 30, 2008
Evidence of epistasis between interleukin 1 and selenoprotein-S with susceptibility to rheumatoid arthritisI Marinou, K Walters, M C Dickson, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 6, 2000
Prevention of bone loss with risedronate in glucocorticoid-treated rheumatoid arthritis patientsR Eastell, J P Devogelaer, N F Peel, et al.
Clinical and Experimental Rheumatology|January 2, 2003
TNF +489 polymorphism does not contribute to susceptibility to rheumatoid arthritisA S Low, M A Gonzalez-Gay, M Akil, et al.
Pageof 2